학술논문

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 9 September 2023, 402(10405):871-881)
Subject
Language
English
ISSN
1474547X
01406736